ASCO 2024

31 May - 4 June 2024, McCormick Place, Booth #30119, Chicago, IL

Seamless oncology drug development from early engagement to clinical delivery

With experience supporting over 800 oncology and haematologic malignancy studies in the past five years, ICON offers the most comprehensive span of clinical development services to plan and deliver oncology clinical trials, including small molecules, biologics, combination products, and companion diagnostics. Our flexible and fully customisable solutions support all elements of drug development from candidate selection through to market authorisation and patient access. 

Meet our experts at ASCO, Booth #30119 to learn about ICON’s full suite of services to support your Oncology clinical development programme.

Meet our experts

Andreas Dreps, Ph.D.

SVP, Drug Development Services

Martin Lachs, Ph.D.

VP, Project Management, Oncology & Cell Therapeutics

Brian Huber, Ph.D.

VP, Drug Development Solutions

Tanja Obradovic, Ph.D.

Vice President, Scientific Affairs

Daniel Ryan

Vice President, Project Delivery

Paul McCracken, Ph.D.

VP, Global Head of Medical Imaging

Tammy Lonjin, MS, MSHS

Executive Director, Oncology Pharma Solutions

Meet Our Experts

Submit our short form to request a meeting with one of our experts